| Company Name | GEXVal Inc. |
| Mailing Address | 12-09 Shonan iPark 2-26-1 Muraoka Higashi, Fujisawa-shi, Kanagawa, 251-8555, Japan |
| Establishment | February 1, 2018 |
| Capital | JPY 10,000,000 (as of December 2024) |
| Representative | Juran Kato |
| Board/Employee | 12 (as of May 2025) |
| Business | Research and development of drugs targeting rare and untreatable diseases |
| Major Shareholders | Mitsubishi UFJ Capital Co Ltd eBEST INVESTMENT & SECURITIES Co Ltd YK VENTURE PARTNERS Co Ltd Alfresa Holdings Corporation TNP Threads Of Light Corporation Takeda Pharmaceutical Co Ltd Juran Kato Axil Capital Advisors KK |
| Subsidiary | GEXVal AU Pty Ltd L 2 169 Pirie St, Adelaide, SA 5000, Australia |
